Those working in Pharma and Biotech aim to advance healthcare, but then programmes are designed, and success often measured, based on financial impact rather than benefit to patients.

This webinar will challenge you to think critically about what you’re doing and why. It will help you connect the changes you want to make with the activities you intend to carry out to achieve those goals. It will provide you with tools to communicate your vision with stakeholders thereby increasing engagement and support. Finally, it will give you a framework to evaluate your effectiveness so you can learn lessons and adapt to maximise your impact.

This event is being hosted by APM in partnership with PIPMG. It is free to attend for PIPMG members.

Click here to register on the APM site: What impact do you want to have in this world? (apm.org.uk)

Description

Join us for an insightful and informative webinar as we explore the complexities and opportunities involved in transitioning from a Contract Research Organization (CRO) to becoming an independent drug developer (Sponsor). We will discuss some early learnings and the important role the PMO plays in an organization currently making this shift. By the end of this webinar, you’ll have a deeper understanding of the critical success factors and potential pitfalls associated with such significant transitions.

Objectives

• Understand how an organization’s history creates its own barriers and opportunities
• Ways to assess existing organizational capabilities and harnessing them
• Hidden factors that influence resistance to new ideas and opportunities
• The importance of speaking the same language – “Product” example
• Building an R&D organization
• The critical role a PMO plays in an organization’s transitions and establishing new ways of working

The marcus evans 17th Edition Project Portfolio and Resource Management Excellence for Pharma conference taking place in Philadelphia, PA on July 11-13, 2023 will present the most recent and useful analysis of management tools, digital technologies, and innovative strategies to grow your company amidst an increasingly difficult regulatory environment and a shift towards targeted medicine that will disrupt the future of pharma. Join your peers from Pharma and Biotech companies and learn how to navigate high-risk ventures and alliances to accomplish the most ambitious of organizational goals.

Attending This Premier marcus evans Conference Will Enable You to:

• Create a clear governance structure to allow for effective decision making
• Allocate Resources Properly Between High and Low-Risk Projects for Less Waste and Sacrifice
• Leverage Lean Thinking and Visual Work as Force Multipliers for Project and Portfolio Management
• Anticipate the impacts of the inflation reduction act into strategy and portfolio planning
• Adapt to changing the function of PMOs and develop a skill set that will propel you into the future
• Optimize external relationships for increased productivity, shortened timelines, and a larger portfolio

Best Practices and Case Studies from:

• Joe Stalder, Executive Director, Project Management,  Mirati Therapeutics
• Abhishek Agrawal, Director US Oncology, Strategy Planning, GSK
• Glen Stambone, Director, Project Management Office, Boehringer Ingelheim
• Michael Ferrante, Executive Director, Business Analytics, Regulatory Affairs and Clinical Safety, Merck
• Saliha Akhtar, Global Drug Development Academy Program Manager, Bristol Myers Squibb
• Saeid Yazdani, Vice President Portfolio Management – Therapeutics Development, Caribou Biosciences

PIPMG members are entitled to $200 discount! For more information please contact: Ms Ria Kiayia, Digital Media and PR Marketing Executive at riak@marcusevanscy.com or visit: https://bit.ly/3HC8oCl